Corrigendum: Murine models of acute myeloid leukemia.

Kurtz, Kristen J; Conneely, Shannon E; O'Keefe, Madeleine; Wohlan, Katharina; Rau, Rachel E

Kurtz, Kristen J; Conneely, Shannon E; O'Keefe, Madeleine; Wohlan, Katharina; Rau, Rachel E.

Afiliação

Kurtz KJ; Department of Pediatrics, Baylor College of Medicine, Texas Children's Hospital, Houston, TX, United States.
Conneely SE; Department of Pediatrics, Baylor College of Medicine, Texas Children's Hospital, Houston, TX, United States.
O'Keefe M; Department of Pediatrics, Baylor College of Medicine, Texas Children's Hospital, Houston, TX, United States.
Wohlan K; Department of Molecular and Cellular Biology, Baylor College of Medicine, Houston, TX, United States.
Rau RE; Department of Pediatrics, Baylor College of Medicine, Texas Children's Hospital, Houston, TX, United States.

Front Oncol ; 12: 1089874, 2022.

Article em En | MEDLINE | ID: mdl-36911791

Palavras-chave

AML; KMT2a (MLL) rearrangements; NUP98 fusion; acute myeloid leukemia; core binding factor acute myeloid leukemia; genetically engineered mice (GEM); patient-derived xenograft (PDX); transgenic mouse

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Prognostic_studies Idioma: En Revista: Front Oncol Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Estados Unidos

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google